Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000623099 | SCV000742560 | pathogenic | Inborn genetic diseases | 2017-08-18 | criteria provided, single submitter | clinical testing | |
SIB Swiss Institute of Bioinformatics | RCV000584728 | SCV000883169 | pathogenic | Combined oxidative phosphorylation deficiency 35 | 2018-10-15 | criteria provided, single submitter | curation | This variant is interpreted as Pathogenic, for Combined oxidative phosphorylation deficiency 35, autosomal recessive. The following ACMG Tag(s) were applied: PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PP3 => Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PP1 => Cosegregation with disease in multiple affected family members in a gene definitively known to cause the disease (https://www.ncbi.nlm.nih.gov/pubmed/24901367). PS3-Very Strong => PS3 upgraded in strength to Very Strong (https://www.ncbi.nlm.nih.gov/pubmed/24901367). |
Neuberg Centre For Genomic Medicine, |
RCV000584728 | SCV005329536 | likely pathogenic | Combined oxidative phosphorylation deficiency 35 | 2023-05-20 | criteria provided, single submitter | clinical testing | The observed missense variant c.968G>A(p.Arg323Gln) in TRIT1 gene has been reported previously in homozygous state inindividuals with Combined oxidative phosphorylation deficiency / mitochondrial disease (Whittaker RG, et al., 2015, Yarham JW, etal., 2014). The c.968G>A variant has 0.001% allele frequency in gnomAD Exomes. A different amino acid change p.Arg323Trp issubmitted to ClinVar as Pathogenic / Likely Pathogenic. This variant has been reported to the ClinVar database as Pathogenic.Theamino acid Arginine at position 323 is changed to a Glutamine changing protein sequence and it might alter its composition andphysico-chemical properties. Multiple lines of computational evidence (Polyphen, SIFT and Mutation Taster) predict a damaging effect on protein structure and function for this variant. The amino acid change p.Arg323Gln in TRIT1 is predicted as conserved byGERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic. |
Gene |
RCV004797839 | SCV005419443 | pathogenic | not provided | 2024-05-31 | criteria provided, single submitter | clinical testing | Reported in an adult with mitochondrial disease and epilepsy (PMID: 26381753); Expression studies in E. coli and yeast found that this variant impaired the isopentenyltransferase activity of TRIT1 (PMID: 24901367); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26857223, 28185376, 24901367, 37393059, 26381753) |
OMIM | RCV000584728 | SCV000692458 | pathogenic | Combined oxidative phosphorylation deficiency 35 | 2018-02-19 | no assertion criteria provided | literature only |